Cited 19 times in
Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.